MED1 and cardiomyopathy: Recently, we demonstrated that cardiomyocyte-specific deletion of Med1 in mice during late gestation, early postnatal development as well as in the adult mice using inducible cardiac Med1-deletion resulted in cardiomyopathy-related dilatation and heart failure.